CAPTRUST Financial Advisors’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $155K | Buy |
30,739
+8,739
| +40% | +$44K | ﹤0.01% | 2341 |
|
|
2025
Q1 | $143K | Buy |
22,000
+1,497
| +7% | +$9.7K | ﹤0.01% | 2208 |
|
|
2024
Q4 | $150K | Buy |
20,503
+4,683
| +30% | +$34.4K | ﹤0.01% | 2174 |
|
|
2024
Q3 | $118K | Buy |
+15,820
| New | +$118K | ﹤0.01% | 2193 |
|
|
2022
Q3 | – | Sell |
-1,823
| Closed | -$46K | – | 4009 |
|
|
2022
Q2 | $46K | Buy |
1,823
+1,690
| +1,271% | +$42.6K | ﹤0.01% | 2821 |
|
|
2022
Q1 | $3K | Sell |
133
-3
| -2% | -$68 | ﹤0.01% | 4395 |
|
|
2021
Q4 | $6K | Buy |
+136
| New | +$6K | ﹤0.01% | 4008 |
|
|
2021
Q1 | – | Sell |
-500
| Closed | -$13K | – | 4481 |
|
|
2020
Q4 | $13K | Buy |
+500
| New | +$13K | ﹤0.01% | 2465 |
|